Incredibly proud of Ye Ethan Li for having his PhD project published in Nat Med. His paper shows that trogocytosis drives relapse post CAR NK therapy & that modulating NK signaling can improve CAR NK efficacy. Congratulations Ethan! @KenChen NV Lab nature.com/articles/s4159…

(1/2) This issue of #Parameters features stories on UH Chemical and Biomolecular Engineering Prof. Gül Zerze's academic path; new grants for NV Lab (immunotherapy) and Katerina Kourentzi (diagnostics); an ASEE award for postdoc Dr. LeShorn Benjamin (with Jerrod Henderson); awards for Profs. Anil Bhowmick, ...

New tech developed at UH Cullen College of Engineering shows promise as a weapon against #lymphoma bit.ly/3TgR8VN #nanotech

Dr. Navin Varadarajan's team (NV Lab) at University of Houston developed a method to identify 🔎 signatures of #ExtracellularVesicle secretion in metastatic #BreastCancer through functional single-cell profiling. More in iScience journal 💡 bit.ly/3LPADzr

Linking extracellular vesicle (EV) secretion to metastasis at the single-cell level Mohsen Fathi UH Chemical and Biomolecular Engineering iScience journal iScience article: rb.gy/awtmw

Celebrating the induction of four of my University of Houston colleagues as senior members of the National Academy of Inventors. Congratulations Navin Varadarajan, TJ Mountziaris, James Briggs and Gomika Udugamasooriya

Trained neural network detects apoptotic bodies of human melanoma cells without fluorescent labeling UH Cullen College of Engineering UH Chemical and Biomolecular Engineering #MachineLearning #Immunology Link: academic.oup.com/bioinformatics…

Congratulations to CellChorus for being announced as a 2023 Houston Innovation Awards finalist in the Life Science Business sector! #startups #innovation #AI #immunology Dan Meyer Link: houston.innovationmap.com/2023-houston-i…

Congratulations to PhD candidate Melisa Montalvo (advisor: NV Lab) in her first-placr poster award at the SHPE National National Convention!

Understanding redundancies in cytotoxic mechanisms employed by CAR T cells in the killing of tumors UH Cullen College of Engineering UH Chemical and Biomolecular Engineering Link: nature.com/articles/s4141…

Next - NV Lab MD Anderson Cancer Center University of Houston is telling us about the metabolic plasticity of T-cell Therapies, with an intriguing title, "digest more fat"! Melanoma Research

An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis UH Cullen College of Engineering UH Chemical and Biomolecular Engineering sciencedirect.com/science/articl…

Check out the latest articles Nature Cancer "Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling" doi.org/10.1038/s43018…

Dynamic functional profiling of T-cell therapies uncover a subset of T cells, labeled CD8-fit, that are motile serial killers and are associated with clinical responses in diffuse B cell lymphoma patients. nature.com/articles/s4301… (No Paywall) singlecell.chee.uh.edu/wp-content/upl…

Team of #cancer researchers, led by University of Houston, discovered new #Tcells that may improve outcome for patients treated with T-cell therapies, especially those suffering from #lymphoma. #lymphoma uh.edu/news-events/st…

Latest UH press release featuring our new Nature Cancer paper! uh.edu/news-events/st… UH Cullen College of Engineering UH Chemical and Biomolecular Engineering University of Houston

CD28 co-stimulation in NK cells? Who knew! New Cancer Discovery paper from Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center showing CD28 costimulation can augment CAR signaling in mature NK cells via the LCK/CD3Z/ZAP70 axis. aacrjournals.org/cancerdiscover…

Many congratulations to our Dr. Sunil Acharya sunil acharya for his exciting research on CD70-targeting CAR NK cells, published in Cancer Discovery! Sunil and his co-authors showed that the incorporation of CD28 costimulation, which is normally absent in NK cells, in the CAR

Dr. Ankita Leekha from the NV Lab led the development of NanoSTING 🦂, a nanoparticle formulation of the endogenous STING agonist, 2′−3′ cGAMP, to function as an immune activator and demonstrated its safety in mice and rats. 🐁 🐀 More here: go.nature.com/4bUds0j

Our latest work was published in Houston Chronicle! University of Houston nasal vaccine prevents COVID from spreading : houstonchronicle.com/news/houston-t…